A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer
AZD4635联合度伐利尤单抗或奥莱克鲁单抗治疗转移性去势抵抗性前列腺癌患者的II期研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-024-03640-6
Falchook, Gerald S; Reeves, James; Gandhi, Sunil; Spigel, David R; Arrowsmith, Edward; George, Daniel J; Karlix, Janet; Pouliot, Gayle; Hattersley, Maureen M; Gangl, Eric T; James, Gareth D; Thompson, Jeff; Russell, Deanna L; Patel, Bhavickumar; Kumar, Rakesh; Lim, Emerson